gadolinium dtpa has been researched along with monodansylcadaverine in 1 studies
Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (monodansylcadaverine) | Trials (monodansylcadaverine) | Recent Studies (post-2010) (monodansylcadaverine) |
---|---|---|---|---|---|
12,654 | 664 | 4,051 | 402 | 0 | 60 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Daemen, MJ; Dirksen, A; Hackeng, TM; Heemskerk, JW; Heeneman, S; HerĂas, MV; Kooi, ME; Lobbes, MB; Miserus, RJ; Prinzen, L; van Engelshoven, JM; Van Suylen, RJ; van Zandvoort, MA | 1 |
1 other study(ies) available for gadolinium dtpa and monodansylcadaverine
Article | Year |
---|---|
Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasmin-based contrast agent.
Topics: alpha-2-Antiplasmin; Animals; Cadaverine; Contrast Media; Disease Models, Animal; Factor XIII; Factor XIIIa; Feasibility Studies; Fibrin; Gadolinium DTPA; Humans; Immunohistochemistry; Magnetic Resonance Imaging; Mice; Microscopy, Fluorescence, Multiphoton; Predictive Value of Tests; Pulmonary Embolism; Reproducibility of Results; Rhodamines; Thrombosis | 2009 |